← Back to home

Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation)

Clinical trials for Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation) explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation) trials appear

Sign up with your email to follow new studies for Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill takes on Hard-to-Treat blood cancers

Disease control Recruiting now

This early-stage trial tests a daily pill called APG-3288 in 180 adults with blood cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will also look for …

Matched conditions: RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL; INCLUDING RICHTER TRANSFORMATION)

Phase 1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation)

Get alerted when new Relapsed/refractory diffuse large B-cell lymphoma (DLBCL; including richter transformation) trials appear

New pill takes on Hard-to-Treat blood cancers